Riskpilot← Back to searchSign inGet full accessNYZU AB
ABActiveOrg 5594094889Upplandsgatan 6Research and experimental development on natural sciences and engineering · NACE 7210Est. 20220 employees
Revenue 2024
SEK 0
EBITDA margin
—
-39% vs 2023
Equity ratio
-916.1%
Financial strength
Net profit 2024
SEK -217K
-79% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -169K | -39% |
| Net profit | SEK -217K | -79% |
| Total assets | SEK 34K | -83% |
| Equity | SEK -313K | -225% |
| Employees | 0 | — |
Legal name
NYZU AB
Org number
5594094889
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
5 december 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska bedriva utveckling och försäljning av mjukvara. Samt bedriva växtförädling med hjälp av den biotekniska lösningen CRISPR. Med tekniken införs nya egenskaper i växter.
Address
Upplandsgatan 6
Email
sebastian.callert@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | −0 | −0 |
| EBITDA | −121 | −169 |
| Depreciation & amort. | — | — |
| EBIT | −121 | −169 |
| Net financials | — | −48 |
| Profit before tax | −121 | −217 |
| Tax | — | — |
| Net profit | −121 | −217 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 204 | 34 |
| Equity | −96 | −313 |
| Long-term debt | 300 | 347 |
| Short-term debt | — | — |
| Total debt | 300 | 347 |
EBITDA margin
-16858800.0%
This company
15.8%
Market median
-106701366% vs market
20232024
Equity ratio
-916.1%
This company
38.2%
Market median
-2498% vs market
20232024
Return on equity
-21650900.0%
This company
18.4%
Market median
-117668035% vs market
20232024
Net profit margin
-21650900.0%
This company
8.1%
Market median
-267295162% vs market
20232024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232024
Debt / equity
1.11×
This company
0.62×
Market median
-79% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2023 | |
| Former (2) | ||
| Board of Directors | 2022 – 2023 | |
| Deputy Board Member | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NYZU AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dennis Carl Eriksson | Chief Executive Officer | 0 companies |
| Stephen William Francois Lindgren | Board of Directors | 0 companies |
| Philip Christoffer Heibö Sundstedt | Deputy Board Member | 0 companies |
| Carl Sebastian Callert | Chairman | 0 companies |
| Stephen William Francois Lindgren | Board of Directors | 0 companies |